KeyBanc Starts United Stationers (USTR) at Hold; Near-Term View of Valuation as Fair
Tweet
Share
E-mailGet Alerts USTR Hot Sheet
Price: $38.84 --0%
Rating Summary:
1 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Rating Summary:
1 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 23 | New: 12
Join SI Premium – FREE
KeyBanc initiates coverage on United Stationers (NASDAQ: USTR) with a Hold.
KeyBanc analyst says, "The Company's main area of exposure is domestic office products, which is a channel facing secular and cyclical headwinds, though USTR is in an advantageous position through its partnership with e-commerce players who are taking share. Furthermore, in the last decade, USTR has developed a jan-san and, more recently, an industrial wholesale business, each of which is driving market share gains and posting growth above the office products categories. As a result, we forecast low single-digit revenue growth, coupled with modest operating margin expansion."
For an analyst ratings summary and ratings history on United Stationers click here. For more ratings news on United Stationers click here.
Shares of United Stationers closed at $32.83 yesterday.
KeyBanc analyst says, "The Company's main area of exposure is domestic office products, which is a channel facing secular and cyclical headwinds, though USTR is in an advantageous position through its partnership with e-commerce players who are taking share. Furthermore, in the last decade, USTR has developed a jan-san and, more recently, an industrial wholesale business, each of which is driving market share gains and posting growth above the office products categories. As a result, we forecast low single-digit revenue growth, coupled with modest operating margin expansion."
For an analyst ratings summary and ratings history on United Stationers click here. For more ratings news on United Stationers click here.
Shares of United Stationers closed at $32.83 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Craig-Hallum Starts Alterity Therapeutics (ATHE) at Buy
- UBS Starts Amcor Plc. (AMCR) at Buy
- Citi initiates Meitu Inc coverage with Buy rating, HK$7 target
Create E-mail Alert Related Categories
New CoverageRelated Entities
KeyBancSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
